Compare ELVA & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELVA | CYRX |
|---|---|---|
| Founded | 1996 | 1999 |
| Country | Canada | United States |
| Employees | N/A | 1100 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 466.7M | 419.3M |
| IPO Year | 2021 | 2008 |
| Metric | ELVA | CYRX |
|---|---|---|
| Price | $9.52 | $16.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $14.00 | $13.31 |
| AVG Volume (30 Days) | 332.1K | ★ 714.9K |
| Earning Date | 05-13-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | $34.68 | $11.06 |
| Revenue Next Year | $51.48 | $8.45 |
| P/E Ratio | $78.51 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.66 | $6.69 |
| 52 Week High | $12.78 | $16.83 |
| Indicator | ELVA | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.72 | 62.25 |
| Support Level | $8.96 | $14.51 |
| Resistance Level | $11.17 | $16.69 |
| Average True Range (ATR) | 0.89 | 0.71 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 38.97 | 80.33 |
Electrovaya Inc is a technology-focused lithium-ion battery company engaged in designing, developing and manufacturing battery cells, modules and systems based on its proprietary Infinity Battery Technology, which provides high safety performance, long cycle life and durability. The Company supplies low-voltage and high-voltage battery systems for industrial and transportation markets, including material-handling equipment, robotic vehicles, electric buses and trucks, and energy-storage installations, and its products are suitable for mission-critical applications. it maintains an expanding intellectual-property portfolio, develops next-generation solid-state and hybrid solid-state battery technologies, and sells its products through OEM relationships, dealer networks and direct sales.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.